newsfilter
← Latest News
Business Wire·

Ionis announces zilganersen New Drug Application for Alexander disease (AxD) accepted by FDA for Priority Review

– PDUFA date set for September 22, 2026 – Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for